Being “drug-free” usually references illegal substance abuse, but prescriptions for chronic pain can lead to damaging dependency as well. For those eager to try a pain reliever that doesn’t require ...
WALTHAM, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of results from a randomized controlled trial of Quell ® in subjects with chronic low back ...
WALTHAM, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported that it will present three scientific posters at the upcoming PAINWeek 2018 National Pain Conference ...
The underlying technology of Quell hasn't changed with Quell 2.0. Like its predecessor, the Quell 2.0 has been approved by the Food and Drug Administration (FDA) through the 510 (k) process as a Class ...